Ontology highlight
ABSTRACT: Purpose
To describe nepafenac use in the Netherlands and Denmark with reference to its approved indications. For context, we also describe the use of ketorolac and diclofenac.Methods
We identified users in the PHARMO Database Network (the Netherlands, 2008-2013) and the Danish national health registers (Denmark, 1994-2014). We described prevalence of cataract surgery and duration of use in patients with cataract surgery with and without diabetes.Results
In the Netherlands, 9530 nepafenac users (mean age, 71 years; 60% women) contributed 12 691 therapy episodes, of which 21% had a recently recorded cataract surgery. Of 2266 episodes in adult non-diabetic patients with cataract surgery, 60% had one bottle dispensed (treatment duration ?21 days). Of 441 episodes in adult diabetic patients with cataract surgery, 90% had up to two bottles dispensed (?60 days). Denmark had 60 403 nepafenac users (mean age, 72 years; 58% women) and 73 648 episodes (41% had recorded cataract surgery). Of 26 649 nepafenac episodes in adult non-diabetic patients with cataract surgery, 92% had one bottle dispensed. Of 3801 episodes in adult diabetic patients with cataract surgery, 99.8% had up to two bottles dispensed. Use patterns of nepafenac, ketorolac and diclofenac were roughly similar in the Netherlands, but not in Denmark.Conclusion
Less than half of therapy episodes were related to cataract surgery; around 90% of episodes with surgery were within the approved duration. Underrecording of ophthalmic conditions and procedures was a challenge in this study.
SUBMITTER: Margulis AV
PROVIDER: S-EPMC5518196 | biostudies-literature | 2017 Aug
REPOSITORIES: biostudies-literature
Margulis Andrea V AV Houben Eline E Hallas Jesper J Overbeek Jetty A JA Pottegård Anton A Torp-Pedersen Tobias T Perez-Gutthann Susana S Arana Alejandro A
Acta ophthalmologica 20170510 5
<h4>Purpose</h4>To describe nepafenac use in the Netherlands and Denmark with reference to its approved indications. For context, we also describe the use of ketorolac and diclofenac.<h4>Methods</h4>We identified users in the PHARMO Database Network (the Netherlands, 2008-2013) and the Danish national health registers (Denmark, 1994-2014). We described prevalence of cataract surgery and duration of use in patients with cataract surgery with and without diabetes.<h4>Results</h4>In the Netherlands ...[more]